US SEC Form D Record

Goldenrod Therapeutics, Inc.

View External Record

SEC Filing Date

Jun 3, 2026

Capital / Financials

$6.5M Raised

Series A (Early Growth)

Registered Location

HOUSTON,

Legal Status

2 Backers

Industry Classification

Biotechnology

Corporate Dossier

Listed Founders / Executives

Leo Linbeck III
Atul Varadhachary
Thomas Brenninkmeijer
Dev Chatterjee
Leo Linbeck IV
Mark Worscheh

Semantic Peers & Competitors ROOT: BIOTECHNOLOGY

Powered by the Semantic Peer Engine. We cross-referenced the semantic root of this entity's industry class against our global SaaS, Enterprise, and SEC venture capital databases to find market parallels.

Venture Backed US

Dewpoint Therapeutics, Inc.

$82.3M Raised

Venture Backed US

Restora Medical, Inc.

$15M Raised